News & Events

Dr. Michael Schwartz (MTE) has been named the Robert H. Williams Endowed Chair in Medicine. Established in 1980, this was the first endowed chair in the UW School of Medicine,

David Cummings, MD, has been named the 2010 Pfizer Visiting Professor in Obesity at the City of Hope National Medical Center.  Pfizer, Inc. awarded 8 Visiting Professorship in Obesity Awards

Michael Schwartz, MD, has been named the 2010 Pfizer Visiting Professor in Obesity at the Baylor College of Medicine. Pfizer, Inc. awarded 8 Visiting Professorship in Obesity Awards in 2010

David Cummings has been awarded an NIH R01 for his proposal entitled “Feasibility, Efficacy, and Mechanisms of Surgical vs Medical Diabetes Treatment.”  This project focuses on mechanisms of the effect of bariatric

Joshua Thaler has been awarded a K08 award from the NIH/NIDDK for his proposal entitled “Cellular Mechanisms of Hypothalamic Inflammation in High Fat Diet-Induced Obesity.”  The goal of this research

Michael W. Schwartz (MTE) has received one of eight 2010 Pfizer Visiting Professorship in Obesity Awards from Pfizer Inc. These $7500 grants support three days of educational activities with a distinguished visiting expert.

Gregory J. Morton (MTE) has been selected as the 2010 recipient of the Perkins Coie Award for Discovery. He will receive $20,000 for his project “Normalization of Blood Glucose Levels in Uncontrolled

D&O Center investigator David Cummings, MD, appeared in a recent KING TV HealthLink news feature about the controversial use of a pregnancy hormone as a weight-loss aid. Dr. Cummings said that human

The UW Diabetes Endocrinology Research Center (DERC) invites applications for Pilot and Feasibility Research Awards to develop new research in the area of diabetes and related metabolic-endocrine disease. New and established investigators may apply for awards of up to $50,000 per year for 1 or 2 years.

David Cummings MD is senior author of an international consensus statement proposing that gastrointestinal surgery may be a viable alternative therapy for type 2 diabetes in some patients and pointing the way toward new directions in research. “The Diabetes Surgery Summit Consensus Conference: Recommendations for the Evaluation and Use of Gastrointestinal Surgery to Treat Type 2 Diabetes Mellitus,” the first such statement on the topic, was published online on November 24 in the Annals of Surgery.